Plain-English translation of NCT07543601 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Many people being evaluated for lung cancer also have a breathing condition called COPD (chronic obstructive pulmonary disease) that often goes undiagnosed. This trial tests whether adding specialized breathing assessments and treatment to standard lung cancer evaluation helps patients feel better and handle cancer treatment more safely. The study compares usual care (lung cancer evaluation only) against a tailored approach that includes breathing tests, medications, smoking cessation support, and referrals to rehabilitation and other specialists as needed.
People with both COPD and lung cancer often tolerate cancer treatments poorly because their lungs are already damaged. Finding and treating COPD early—before cancer treatment begins—may improve lung function, reduce complications, and help patients recover better from surgery, chemotherapy, or radiation.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will continue with your regular lung cancer evaluation. Depending on which group you are randomly assigned to, you may also receive specialized breathing consultations that include assessment of your lung function, medications to improve breathing, referrals to smoking cessation programs, pulmonary rehabilitation, nutrition support, heart evaluation, and sleep apnea screening as appropriate. The study aims to show whether this extra breathing care improves outcomes for people facing both lung cancer and breathing problems.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Denmark